These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35556223)

  • 1. Screening and Referral Practices for Nonalcoholic Fatty Liver Disease by Race and Ethnicity in a Primary Care Clinic.
    Patil R; Nagaraj PK; Kuo HC; Noel G
    J Racial Ethn Health Disparities; 2023 Jun; 10(3):1392-1397. PubMed ID: 35556223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.
    Frediani JK; Naioti EA; Vos MB; Figueroa J; Marsit CJ; Welsh JA
    Environ Health; 2018 Jan; 17(1):6. PubMed ID: 29334960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.
    El Khoudary SR; Samargandy S; Zeb I; Foster T; de Boer IH; Li D; Budoff MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):114-122. PubMed ID: 31761548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.
    Bazick J; Donithan M; Neuschwander-Tetri BA; Kleiner D; Brunt EM; Wilson L; Doo E; Lavine J; Tonascia J; Loomba R
    Diabetes Care; 2015 Jul; 38(7):1347-55. PubMed ID: 25887357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening patterns and identification of non-alcoholic fatty liver disease in obese children in canadian primary care.
    Theal R; Morkem R; Queenan J; Barber D
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease.
    Schwimmer JB; Newton KP; Awai HI; Choi LJ; Garcia MA; Ellis LL; Vanderwall K; Fontanesi J
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1267-77. PubMed ID: 24117728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease.
    Dowla S; Aslibekyan S; Goss A; Fontaine K; Ashraf AP
    J Clin Lipidol; 2018; 12(4):981-987. PubMed ID: 29699915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.
    Schwimmer JB; McGreal N; Deutsch R; Finegold MJ; Lavine JE
    Pediatrics; 2005 May; 115(5):e561-5. PubMed ID: 15867021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association Between Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease Diagnosis Varies by Race.
    Mahabaleshwarkar R; Liu TL; McKillop IH; Spencer M
    Metab Syndr Relat Disord; 2022 Jun; 20(5):286-294. PubMed ID: 35319282
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study.
    Shaheen AA; Riazi K; Medellin A; Bhayana D; Kaplan GG; Jiang J; Park R; Schaufert W; Burak KW; Sargious M; Swain MG
    CMAJ Open; 2020; 8(2):E370-E376. PubMed ID: 32414883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Patterns of Nonalcoholic Fatty Liver Disease in Children with Obesity in Canadian Primary Care: A Cross-Sectional Study.
    Morkem R; Theal R; Barber D; Flemming J; Queenan J; Kehar M
    Can J Gastroenterol Hepatol; 2022; 2022():8435581. PubMed ID: 36594051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients.
    Sebastiani G; Cocciolillo S; Mazzola G; Malagoli A; Falutz J; Cervo A; Petta S; Pembroke T; Ghali P; Besutti G; Franconi I; Milic J; Cascio A; Guaraldi G
    HIV Med; 2020 Feb; 21(2):96-108. PubMed ID: 31642599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017.
    Kim MJ; Lee KJ
    BMC Pediatr; 2020 Mar; 20(1):121. PubMed ID: 32171275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
    Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016.
    Le MH; Yeo YH; Cheung R; Wong VW; Nguyen MH
    J Intern Med; 2020 Jun; 287(6):711-722. PubMed ID: 32128904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence of Elevated Alanine Aminotransferase Levels Meeting Clinical Action Thresholds in Children with Obesity in Primary Care Practice.
    Wu SJ; Darbinian JA; Schwimmer JB; Yu EL; Ramalingam ND; Greenspan LC; Lo JC
    J Pediatr; 2022 Jan; 240():280-283. PubMed ID: 34562443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased prevalence of nonalcoholic fatty liver disease in black obese children.
    Louthan MV; Theriot JA; Zimmerman E; Stutts JT; McClain CJ
    J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):426-9. PubMed ID: 16205510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease is underrecognized in the primary care setting.
    Blais P; Husain N; Kramer JR; Kowalkowski M; El-Serag H; Kanwal F
    Am J Gastroenterol; 2015 Jan; 110(1):10-4. PubMed ID: 24890441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of a dedicated care pathway for nonalcoholic fatty liver disease in an integrated US healthcare system demonstrates support of weight management and improved ALT.
    Patton H; Burchette R; Tovar S; Pio J; Shi J; Nyberg LM
    BMC Gastroenterol; 2020 Oct; 20(1):362. PubMed ID: 33129272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.